Robert Lisicki Insider Trading $ARNA ARENA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Lisicki.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Lisicki. Robert Lisicki is EVP, Chief Commercial Officer in ARENA PHARMACEUTICALS INC ($ARNA).
Robert Lisicki in ARENA PHARMACEUTICALS INC
Trading Symbol: ARNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Lisicki: EVP, Chief Commercial Officer
Holdings: 16,101 shares
Current Value: $23,990
Latest Transaction: Mar 03 2021
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert Lisicki in ARENA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 40.95 | 17,500 | 716,625 | 127,500 | |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 79.35 | 9,359 | 742,637 | 9,441 | 18.8 K to 9.4 K (-49.78 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 78.50 | 6,400 | 502,394 | 18,800 | 25.2 K to 18.8 K (-25.40 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 77.70 | 1,741 | 135,278 | 25,200 | 26.9 K to 25.2 K (-6.46 %) |
Feb 04 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 40.95 | 17,500 | 716,625 | 26,941 | 9.4 K to 26.9 K (+185.36 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 77.59 | 3,159 | 245,107 | 9,441 | 12.6 K to 9.4 K (-25.07 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 12,600 | 0 | 12,600 | 0 to 12.6 K |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 12,600 | 0 | 0 | |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 77.59 | 3,159 | 245,107 | 9,441 | 12.6 K to 9.4 K (-25.07 %) |
Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 12,600 | 0 | 12,600 | 0 to 12.6 K |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 66.72 | 550 | 36,697 | 0 | 550 to 0 (-100.00 %) |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 66.06 | 3,022 | 199,629 | 550 | 3.6 K to 550 (-84.60 %) |
Dec 03 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 64.87 | 300 | 19,460 | 3,572 | 3.9 K to 3.6 K (-7.75 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 6,300 | 0 | 12,600 | |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 65.50 | 2,428 | 159,034 | 3,872 | 6.3 K to 3.9 K (-38.54 %) |
Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 40.95 | 30,000 | 1,228,500 | 115,000 | |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 63.58 | 22,575 | 1,435,298 | 0 | 22.6 K to 0 (-100.00 %) |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 62.63 | 7,425 | 465,047 | 22,575 | 30 K to 22.6 K (-24.75 %) |
Aug 06 2020 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 40.95 | 30,000 | 1,228,500 | 30,000 | 0 to 30 K |
Nov 26 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Sell | S | 45.83 | 4,429 | 203,000 | 0 | 4.4 K to 0 (-100.00 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 6,300 | 0 | 18,900 | |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 47.32 | 1,871 | 88,536 | 4,429 | 6.3 K to 4.4 K (-29.70 %) |
Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Buy | M | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Page: 1